LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS AT 64 WEEKS

  • Zeng, X.
  • Zhao, D.
  • Radominski, S.
  • Keiserman, M.
  • Lee, C. K.
  • 외 4명
Citations

WEB OF SCIENCE

0
제목
LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS AT 64 WEEKS
저자
Zeng, X.Zhao, D.Radominski, S.Keiserman, M.Lee, C. K.Martin, N.Meerwein, S.Sui, Y.Park, W.
DOI
10.1136/annrheumdis-2021-eular.1807
발행일
2021-06
유형
Meeting Abstract
저널명
Annals of the Rheumatic Diseases
80
페이지
1156 ~ 1157